Bonus BioGroup Company Top Insiders
| BBIXF Stock | USD 0.02 0.00 0.00% |
Bonus BioGroup employs about 4 people. The company is managed by 4 executives with a total tenure of roughly 10 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of Bonus BioGroup's management performance can provide insight into the company performance.
| Joseph MBA Insider Ex Chairman |
| Vered Kivity Insider Head Affairs |
Bonus |
Bonus BioGroup Management Team Effectiveness
The company has return on total asset (ROA) of (0.0636) % which means that it has lost $0.0636 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5522) %, meaning that it generated substantial loss on money invested by shareholders. Bonus BioGroup's management efficiency ratios could be used to measure how well Bonus BioGroup manages its routine affairs as well as how well it operates its assets and liabilities.Bonus BioGroup Workforce Comparison
Bonus BioGroup is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 25,614. Bonus BioGroup adds roughly 4.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
Bonus BioGroup Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Bonus BioGroup Price Series Summation is a cross summation of Bonus BioGroup price series and its benchmark/peer.
Bonus BioGroup Notable Stakeholders
A Bonus BioGroup stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Bonus BioGroup often face trade-offs trying to please all of them. Bonus BioGroup's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Bonus BioGroup's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Joseph MBA | Ex Chairman | Profile | |
| Vered Kivity | Head Affairs | Profile | |
| Shai Meretzki | CEO, Founder | Profile | |
| Yoni CPA | Chief Officer | Profile |
About Bonus BioGroup Management Performance
The success or failure of an entity such as Bonus BioGroup often depends on how effective the management is. Bonus BioGroup management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bonus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bonus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Bonus BioGroup Ltd., a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts. Bonus BioGroup Ltd. was founded in 1981 and is based in Haifa, Israel. Bonus Biogroup is traded on OTC Exchange in the United States.
Bonus BioGroup Workforce Analysis
Traditionally, organizations such as Bonus BioGroup use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Bonus BioGroup within its industry.Bonus BioGroup Manpower Efficiency
Return on Bonus BioGroup Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 22.5M | |
| Net Loss Per Executive | 22.5M |
Complementary Tools for Bonus Pink Sheet analysis
When running Bonus BioGroup's price analysis, check to measure Bonus BioGroup's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bonus BioGroup is operating at the current time. Most of Bonus BioGroup's value examination focuses on studying past and present price action to predict the probability of Bonus BioGroup's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bonus BioGroup's price. Additionally, you may evaluate how the addition of Bonus BioGroup to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |